Cyclosporine in dermatology

https://doi.org/10.1016/S0190-9622(89)70339-XGet rights and content

Cyclosporine is a potent immunosuppressive agent with no appreciable effect on the bone marrow and a selective inhibitory effect on helper T cells. Oral cyclosporine was first used to prevent organ rejection but also has been reported to be effective in other disorders. In cutaneous diseases that respond to oral cyclosporine helper T cells appear to be involved in their pathogenesis. This article reviews the cutaneous diseases that have been treated with cyclosporine and its pharmacology and side effects. Two significant adverse side effects are renal dysfunction and hypertension, both of which are reversible when short-term low-dose (less than 5 mg/kg per day) oral cyclosporine is discontinued. Lymphoma is unlikely in an otherwise healthy patient who has received low-dose oral cyclosporine for limited periods. The use of oral cyclosporine in any patient should be carefully considered in terms of the risk/benefit ratio and needs to be carried out under close medical supervision. In view of the limited experience with cyclosporine in dermatology, whenever possible its use should be confined to formal clinical studies with established protocols and guidelines. Further controlled studies need to be performed to evaluate the efficacy of low-dose Cyclosporine in many dermatoses and its side-effect profile, particularly over the long term.

References (152)

  • H Zachariae

    Cyclosporin A in epidermolysis bullosa acquisita

    J Am Acad Dermatol

    (1987)
  • LL Crow et al.

    Clearing of epidermolysis bullosa acquisita with cyclosporine

    J Am Acad Dermatol

    (1988)
  • TH Totterman et al.

    Cyclosporin A is selectively cytotoxic to human leukemic T cells in vitro

    Blood

    (1982)
  • AA Moreland et al.

    Treatment of cutaneous T cell lymphoma with cyclosporin A

    [Letter.] J Am Acad Dermatol

    (1985)
  • K Bendtzen et al.

    Cyclosporin for polymyositis

    Lancet

    (1984)
  • P Zabel et al.

    Cyclosporin for acute dermatomyositis

    Lancet

    (1984)
  • G Maurer

    Metabolism of cyclosporine

    Transplant Proc

    (1985)
  • JF Borel et al.

    Effects of the new anti-lymphocyte peptide cyclosporin A in animals

    Immunology

    (1977)
  • T Beveridge et al.

    Cyclosporin A: pharmacokinetics after a single dose in man and serum levels after multiple dosing in recipients of allogenic bone marrow grafts

    Curr Ther Res

    (1981)
  • BD Kahan et al.

    Immunopharmacologic monitoring of cyclosporin A treated recipients of cadaveric kidney allografts

    Transplantation

    (1982)
  • AG Gillman et al.
  • AJ Wood et al.

    Cyclosporine: pharmacokinetics, metabolism and drug interactions

    Transplant Proc

    (1983)
  • RJ Ptachcinski et al.

    Clinical pharmacokinetics of cyclosporin

    Clin Pharmacoldnet

    (1986)
  • F Follath et al.

    Intravenous cyclosporine kinetics in renal failure

    Clin Pharmacol Ther

    (1983)
  • S Gibbons et al.

    Comparison and correlation of assays for monitoring cyclosporine drug levels in renal transplant patients

    Transplant Proc

    (1988)
  • WT Robinson et al.

    Methods to measure cyclosporine levels—high-performance liquid chromatography, radioimmunoassay and correlation

    Transplant Proc

    (1983)
  • TJ Schroeder et al.

    Comparison of Abbott TDx fluorescence polarization immunoassay, Sandoz radioimmunoassay and high-performance liquid chromatography methods for the assay of serum cyclosporine

    Transplant Proc

    (1988)
  • I Cockburn

    Cyclosporine A: a clinical evaluation of drug interactions

    Transplant Proc

    (1986)
  • NK Wadhwa et al.

    Cyclosporine drug interactions: a review

    Ther Drug Mon

    (1987)
  • M Contarovich et al.

    Confirmation of the interaction between cyclosporine and the calcium channel blacker nicardipine in renal transplant patients

    Clin Nephrol

    (1987)
  • DK Jones et al.

    Serious interaction between cyclosporine A and sulphadimidine

    Br Med J

    (1986)
  • WM Bennet et al.

    Action and toxicity of cyclosporine

    Ann Rev Med

    (1986)
  • EM Shevach

    The effects of cyclosporine A on the immune system

    Ann Rev Immunol

    (1985)
  • Cooper KD, Baadsgaard O, Brown M, et al. Cyclosporine A therapy for psoriasis depletes infiltrating epidermal antigen...
  • Ho VC, Griffiths CEM, Ellis CN, et al. Intralesional cyclosporine in the treatment of psoriasis. A clinical,...
  • RA Kroczek et al.

    Mechanism of action of cyclosporin A in vivo

    J Immunol

    (1987)
  • Gupta AK, Baadsgaard O, Ellis CN, et al. Epidermal and dermal lymphocytes and macrophages in lesional psoriatic skin,...
  • BS Baker et al.

    T-cell subpopulations in the blood and skin of patients with psoriasis

    Br J Dermatol

    (1984)
  • BS Baker et al.

    The effects of cyclosporin A on T lymphocyte and dendritic cell sub-populations in psoriasis

    Br J Dermatol

    (1987)
  • DJ Cohen et al.

    Cyclosporine: a new immunosuppressive agent for organ transplantation

    Ann Intern Med

    (1984)
  • M Furue et al.

    Cyclosporine A inhibits antigen-presenting and accessory cell functions of Langerhans cells [Abstract]

    J Invest Dermatol

    (1987)
  • BJ Nickoloff et al.

    Direct cytopathic effects of cyclosporine A on rapidly proliferating cultured keratinocytes and dermal fibroblasts

    Transplant Proc

    (1988)
  • Gupta AK, Fisher GJ, Elder JT, et al. Topical cyclosporine A inhibits the phorbol ester-induced hyperplastic...
  • RE Handschumacher et al.

    Cyclophilin: a specific cytosolic binding protein for cyclosporine A

    Science

    (1984)
  • PM Colombani et al.

    Cyclosporine A binding to calmodulin: a possible site of action on T lymphocytes

    Science

    (1985)
  • DH Russell et al.

    Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporin

    J Immunol

    (1985)
  • W Mueller et al.

    Cyclosporin A for psoriasis

    N Engl J Med

    (1979)
  • W Muller et al.

    Die Behandlung der Psoriasis-Arthritis mit Cyclosporin A, einem neuen Immunosuppressivum

    Schweiz Med Wochenschr

    (1981)
  • JP van Hooff et al.

    Cyclosporine and psoriasis

    Lancet

    (1985)
  • TH van Joost et al.

    Short-term use of cyclosporine A in severe psoriasis

    Br J Dermatol

    (1986)
  • Cited by (0)

    Supported in part by the Babcock Endowment Fund.

    View full text